Sort
30,917 grants matching “tumor microenvironment”
IGFBP1 mediates a liver-bone-muscle axis in colorectal cancer cachexia
$408,037Andrea Bonetto · University Of Colorado Denver · R01 · FY2024 · AR
Understanding the Behavior of Novel IL13Ralpha2-directed T cell Engager for GBM
$408,013Irina V Balyasnikova · Northwestern University At Chicago · R01 · FY2022 · NS
Chemotherapy delivery with nanoparticles for targeted induction of immunogenic cell death
$407,966Yoon Yeo · Purdue University · R01 · FY2021 · CA
Chemotherapy delivery with nanoparticles for targeted induction of immunogenic cell death
$407,966Yoon Yeo · Purdue University · R01 · FY2020 · CA
Informatics Tools To Analyze And Model Whole Slide Image Data At The Single Cell Level
$407,930Guanghua Xiao · Ut Southwestern Medical Center · U01 · FY2021 · CA
Proteases in Prostate Cancer Bone Metastasis
$407,908Wayne State University · R01 · FY2005 · DK
Tumor microenvironment-dependent therapy resistance
$407,872Shahab Asgharzadeh · Children'S Hosp Of Philadelphia · P01 · FY2025 · CA
Leveraging biological insights to enhance immunotherapies
$407,870Robbie G. Majzner · Children'S Hosp Of Philadelphia · P01 · FY2025 · CA
Translational, statistical, and clinical trials core
$407,869Julie R Park · Children'S Hosp Of Philadelphia · P01 · FY2025 · CA
Integration of Genomic and Clinical Data to Enhance Subtyping of Colon Cancer
$407,754Frank A Sinicrope · Mayo Clinic Rochester · R01 · FY2021 · CA
Project 2: Characterizing and overcoming failure to respond to PD-1 blockade therapy
$407,751Paul Nghiem · University Of Washington · P01 · FY2022 · CA
Rapid Motion-Robust and Easy-to-Use Dynamic Contrast-Enhanced MRI for Liver Perfusion Quantification
$407,721Li Feng · New York University School Of Medicine · R01 · FY2023 · EB
IDO2 Targeting in Pancreatic Cancer
$407,668George C Prendergast · Lankenau Institute For Medical Research · R01 · FY2015 · CA
Improving response to immunotherapy by genistein and antiestrogens
$407,663Leena A Hilakivi-Clarke · University Of Minnesota · R21 · FY2021 · CA
Efficacy and Safety of a Novel, Implantable Drug-eluting Film in Sarcoma
$407,644Yolonda L Colson · Brigham And Women'S Hospital · R01 · FY2017 · EB
Identifying host factors that block engraftment and progression of transmissible cancer as a model of AML
$407,599Michael Jeffrey Metzger · Pacific Northwest Research Institute · R01 · FY2022 · CA
The Role of CXCL12 Signaling in Obesity-Induced Prostate Cancer Progression
$407,569John Digiovanni · University Of Texas At Austin · R01 · FY2015 · CA
Role of Receptor for Advanced Glycation End Product (RAGE) Pathway in Brain Tumors
$407,551Behnam Badie · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
Role of Hypoxia in Shaping the Tumor Stroma in Pancreatic Cancer
$407,542Kyoung Eun Lee · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Cold-responsive gene and drug delivery-potentiated cryoimmunotherapy
$407,483Wenquan Ou · Univ Of Maryland, College Park · R01 · FY2025 · CA
Modulation of Anti-Tumor Immunity by Inhibitory Receptors
$407,472Dario Aa Vignali · University Of Pittsburgh At Pittsburgh · P01 · FY2017 · AI
Targeting the cytokine circuitry of KRAS-driven lung cancer
$407,428David A Barbie · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Targeting the cytokine circuitry of KRAS-driven lung cancer
$407,428David A Barbie · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Novel chemokine in the regulation of breast cancer metastasis
$407,391Dev Karan · University Of Louisville · R21 · FY2024 · CA
Project 1: Deciphering the Dynamic Evolution of the Tumor-Neural Interface
$407,357Nathalie Yr Agar · Massachusetts Institute Of Technology · U54 · FY2024 · CA